November MIMS Update

We look at some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products  Andexanet alfa (Andexxa) is a recombinant form of human factor Xa (FXa) protein that has been modified to lack FXa enzymatic activity. The active site serine was substituted with alanine, rendering the molecule unable to

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Reporting culture
Next World news wrapup: 2 November 2023